NON-PEPTIDYL POLYMER-INSULIN MULTIMER AND METHOD FOR PRODUCING THE SAME
    4.
    发明申请
    NON-PEPTIDYL POLYMER-INSULIN MULTIMER AND METHOD FOR PRODUCING THE SAME 有权
    非肽聚合物 - 胰岛素多元及其生产方法

    公开(公告)号:US20140107023A1

    公开(公告)日:2014-04-17

    申请号:US14123258

    申请日:2012-06-01

    IPC分类号: C07K14/62

    摘要: The present invention relates to a non-peptidyl polymer-insulin multimer comprising two or more of a non-peptidyl polymer-insulin conjugate prepared by linking a non-peptidyl polymer and insulin via a covalent bond, in which the conjugates are complexed with cobalt ion to form a multimer, a method and kit for the preparation of the multimer, a pharmaceutical composition for the prevention or treatment of diabetes comprising the multimer as an active ingredient, and a method for preventing or treating diabetes by administering the composition to a subject.

    摘要翻译: 本发明涉及一种非肽基聚合物 - 胰岛素多聚体,其包含通过共价键连接非肽基聚合物和胰岛素而制备的两种或多种非肽基聚合物 - 胰岛素结合物,其中缀合物与钴离子络合 以形成多聚体的制备方法和试剂盒,用于预防或治疗糖尿病的药物组合物,其包含多聚体作为活性成分,以及通过向受试者施用该组合物来预防或治疗糖尿病的方法。

    METHOD FOR MASS PRODUCTION OF FACTOR VII/VIIA
    5.
    发明申请
    METHOD FOR MASS PRODUCTION OF FACTOR VII/VIIA 有权
    大量生产VII / VIIA因子的方法

    公开(公告)号:US20130273634A1

    公开(公告)日:2013-10-17

    申请号:US13881974

    申请日:2011-10-26

    IPC分类号: C12N9/64

    摘要: A method for the mass production of human coagulation factor VII. The method includes a) providing an expression vector carrying i) a dihydrofolate reductase promoter devoid of one or more CCGCC repeat sequences from the GC-rich region thereof and a dihydrofolate reductase (DHFR) gene operably linked thereto and ii) a cytomegalovirus (CMV) promoter and a human coagulation factor VII gene operably linked thereto; b) obtaining a transformed a host cell line containing the expression vector; and c) culturing the transfected host cell in the presence of a dihydrofolate reductase inhibitor to select cells which express human coagulation factor VII with high efficiency; and d) adding sodium butyrate to the selected host cells.

    摘要翻译: 大量生产人凝血因子VII的方法。 所述方法包括:a)提供表达载体,其携带i)没有来自其富含GC的区域的一个或多个CCGCC重复序列的二氢叶酸还原酶启动子和与其可操作地连接的二氢叶酸还原酶(DHFR)基因,和ii)巨细胞病毒(CMV) 启动子和与之有效连接的人凝血因子VII基因; b)获得含有表达载体的转化的宿主细胞系; 和c)在二氢叶酸还原酶抑制剂存在下培养转染的宿主细胞以选择以高效率表达人凝血因子VII的细胞; 和d)向所选择的宿主细胞中加入丁酸钠。

    LIQUID FORMULATIONS FOR LONG-ACTING G-CSF CONJUGATE
    10.
    发明申请
    LIQUID FORMULATIONS FOR LONG-ACTING G-CSF CONJUGATE 有权
    用于长时间运动G-CSF凝血液的液体制剂

    公开(公告)号:US20120294829A1

    公开(公告)日:2012-11-22

    申请号:US13574039

    申请日:2011-01-18

    IPC分类号: A61K38/19

    摘要: Disclosed is a liquid formulation which allows long-acting G-CSF conjugates, that have improved in vivo duration and stability, to be stable when stored for a long period of time. It comprises a stabilizer composition characterized by buffer and mannitol. Being free of human serum albumin and other potential factors harmful to the body, the liquid formulation is free of concerns about viral infections and guarantees excellent storage stability to long-acting G-CSF conjugates.

    摘要翻译: 本发明公开了一种允许长效G-CSF缀合物的液体制剂,其具有改善的体内持续时间和稳定性,在长时间储存​​时是稳定的。 它包括以缓冲液和甘露醇为特征的稳定剂组合物。 没有人体血清白蛋白和其他对身体有害的潜在因素,液体制剂没有对病毒感染的担忧,并保证了对长效G-CSF缀合物的极好的储存稳定性。